Prevention and Control of Herpesvirus Diseases. Part 2. Epidemiology and Immunology

Overview

Journal Bull World Health Organ

Specialty Public Health

Date 1985 Jan 1

PMID 2994897

Citations 1

Affiliations

Soon will be listed here.

Abstract

This is the second of two articles summarizing the information currently available on herpes virus diseases. The first described the different members of the herpesvirus group, clinical expression of infection, laboratory diagnosis, and chemotherapy. This article dealing with the epidemiological and immunological aspects of herpesvirus infections also brings up the special problems caused by virus latency and risks associated with congenital infection and immunodeficiency or immunodepressive treatment. The prospects of preventing herpesvirus infections by vaccination and treatment with immune sera are also discussed.

Citing Articles

Prevalence of antibodies to herpes simplex virus type 1 in different population groups in Italy.

Franco E, CAPRILLI F, Zaratti L, Pasquini P Eur J Clin Microbiol. 1987; 6(3):322.

PMID: 3040393 DOI: 10.1007/BF02017628.

References

Glezen W, Fernald G, Lohr J . Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis. Am J Epidemiol. 1975; 101(2):111-21. DOI: 10.1093/oxfordjournals.aje.a112077. View

Embil J, STEPHENS R, Manuel F . Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J. 1975; 113(7):627-30. PMC: 1956715. View

Vestergaard B, Grauballe P . ELISA for herpes simplex virus (HSV) type-specific antibodies in human sera using HSV type 1 and type 2 polyspecific antigens blocked with type-heterologous rabbit antibodies. Acta Pathol Microbiol Scand B. 1979; 87(4):261-3. DOI: 10.1111/j.1699-0463.1979.tb02436.x. View

De Clercq E, Descamps J, Verhelst G, Walker R, Jones A, Torrence P . Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis. 1980; 141(5):563-74. DOI: 10.1093/infdis/141.5.563. View

Gershon A . Live attenuated Varicella-Zoster vaccine. Rev Infect Dis. 1980; 2(3):393-407. DOI: 10.1093/clinids/2.3.393. View

Yeager A, Grumet F, Hafleigh E, Arvin A, Bradley J, Prober C . Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr. 1981; 98(2):281-7. DOI: 10.1016/s0022-3476(81)80662-2. View

REEVES W, Corey L, ADAMS H, Vontver L, Holmes K . Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med. 1981; 305(6):315-9. DOI: 10.1056/NEJM198108063050604. View

SCHMIDT N, Gallo D, Devlin V, WOODIE J, Emmons R . Direct immunofluorescence staining for detection of herpes simplex and varicella-zoster virus antigens in vesicular lesions and certain tissue specimens. J Clin Microbiol. 1980; 12(5):651-5. PMC: 273664. DOI: 10.1128/jcm.12.5.651-655.1980. View

Pereira L, Dondero D, Gallo D, Devlin V, WOODIE J . Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect Immun. 1982; 35(1):363-7. PMC: 351039. DOI: 10.1128/iai.35.1.363-367.1982. View

10.

Glenn J . Cytomegalovirus infections following renal transplantation. Rev Infect Dis. 1981; 3(6):1151-78. DOI: 10.1093/clinids/3.6.1151. View

11.

Nahmias A, Whitley R, Visintine A, Takei Y, Alford Jr C . Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis. 1982; 145(6):829-36. DOI: 10.1093/infdis/145.6.829. View

12.

Baba K, Hurley P, Yabuuchi H, Takahashi M, Ogra P . Antibody response to varicella-zoster virus after natural or vaccine-induced infection. J Infect Dis. 1982; 146(2):260-5. DOI: 10.1093/infdis/146.2.260. View

13.

Whitley R, Lakeman A, Nahmias A, Roizman B . Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982; 307(17):1060-2. DOI: 10.1056/NEJM198210213071706. View

14.

Kawana T, Kawagoe K, Takizawa K, Chen J, Kawaguchi T, Sakamoto S . Clinical and virologic studies on female genital herpes. Obstet Gynecol. 1982; 60(4):456-61. View

15.

Sarov B, Naggan L, Rosenzveig R, Katz S, Haikin H, Sarov I . Prevalence of antibodies to human cytomegalovirus in urban, kibbutz, and Bedouin children in southern Israel. J Med Virol. 1982; 10(3):195-201. DOI: 10.1002/jmv.1890100305. View

16.

Shigeta S, Yokota T, Iwabuchi T, Baba M, Konno K, Ogata M . Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. J Infect Dis. 1983; 147(3):576-84. DOI: 10.1093/infdis/147.3.576. View

17.

Corey L, ADAMS H, Brown Z, Holmes K . Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983; 98(6):958-72. DOI: 10.7326/0003-4819-98-6-958. View

18.

Corey L, Holmes K . Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med. 1983; 98(6):973-83. DOI: 10.7326/0003-4819-98-6-973. View

19.

Young C, Schneider R, Leyland-Jones B, Armstrong D, Tan C, Lopez C . Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection. Cancer Res. 1983; 43(10):5006-9. View

20.

Dworsky M, Welch K, CASSADY G, Stagno S . Occupational risk for primary cytomegalovirus infection among pediatric health-care workers. N Engl J Med. 1983; 309(16):950-3. DOI: 10.1056/NEJM198310203091604. View